Affordable Access

Resveratrol in cancer: cellular and mitochondrial consequences of proton transport inhibition.

Authors
  • Lopez-Lluch, Guillermo1
  • Cruz-Calvo, Sara Santa
  • Navas, Placido
  • 1 Centro Andaluz de Biologia del Desarrollo, Universidad Pablo de Olavide, Carretera de Utrera Km. 1, 41013 Sevilla, Spain. [email protected] , (Spain)
Type
Published Article
Journal
Current pharmaceutical design
Publication Date
Jan 01, 2012
Volume
18
Issue
10
Pages
1338–1344
Identifiers
PMID: 22360556
Source
Medline
License
Unknown

Abstract

Transformed cells suffer several changes leading to the increase of protective mechanisms and show a metabolic profile in accordance with higher proliferative capacity. In these mechanisms, changes in mitochondrial activity cause a higher glycolytic metabolism in detriment of oxidative phosphorylation. In these changes, H⁺-ATPase regulation seems to be importantly involved. During the last years, polyphenols and specially the stilbene resveratrol and related members of its family have been studied because they are able to affect tumour cell growth and cancer progression. Among the different effects induced by resveratrol, inhibition of H⁺-ATPase seems to be one important mechanism in its effect on cancer progression. Further, an ectopic H⁺-ATPase located in the outer surface of plasma membrane has been recently involved in cancer progression and angiogenesis. In this article we review the latest findings about resveratrol inhibition of H⁺-ATPase and its importance in tumour cell growth and cancer progression.

Report this publication

Statistics

Seen <100 times